Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 289 to 290 of 290 entries
Sorted by: Best Match Show Resources per page
Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study.

Frontiers in cardiovascular medicine

Beyhoff N, Lohr D, Thiele A, Foryst-Ludwig A, Klopfleisch R, Schreiber LM, Kintscher U.
PMID: 33330644
Front Cardiovasc Med. 2020 Nov 19;7:580296. doi: 10.3389/fcvm.2020.580296. eCollection 2020.

Although heart failure following myocardial infarction (MI) represents a major health burden, underlying microstructural and functional changes remain incompletely understood. Here, we report on a case of unexpected MI after treatment with the catecholamine isoproterenol in an experimental imaging...

Cite
Beyhoff N, Lohr D, Thiele A, et al. Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study. Front Cardiovasc Med. 2020;7:580296doi: 10.3389/fcvm.2020.580296.
Beyhoff, N., Lohr, D., Thiele, A., Foryst-Ludwig, A., Klopfleisch, R., Schreiber, L. M., & Kintscher, U. (2020). Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study. Frontiers in cardiovascular medicine, 7580296. https://doi.org/10.3389/fcvm.2020.580296
Beyhoff, Niklas, et al. "Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study." Frontiers in cardiovascular medicine vol. 7 (2020): 580296. doi: https://doi.org/10.3389/fcvm.2020.580296
Beyhoff N, Lohr D, Thiele A, Foryst-Ludwig A, Klopfleisch R, Schreiber LM, Kintscher U. Myocardial Infarction After High-Dose Catecholamine Application-A Case Report From an Experimental Imaging Study. Front Cardiovasc Med. 2020 Nov 19;7:580296. doi: 10.3389/fcvm.2020.580296. eCollection 2020. PMID: 33330644; PMCID: PMC7717942.
Copy Download .nbib Format: NLM
[No title available]

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Schreiber M, Ahmad T, Scott M, Imrie K, Razack S.
PMID: 34860696
CMAJ. 2021 Jun 14;193(24):E937-E941. doi: 10.1503/cmaj.202642-f.

No abstract available.

Cite
Schreiber M, Ahmad T, Scott M, et al. Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine. . CMAJ. 2021;193(24):E937-E941doi: 10.1503/cmaj.202642-f.
Schreiber, M., Ahmad, T., Scott, M., Imrie, K., & Razack, S. (2021). Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine. . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 193(24), E937-E941. https://doi.org/10.1503/cmaj.202642-f
Schreiber, Miranda, et al. "Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine." . CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 193,24 (2021): E937-E941. doi: https://doi.org/10.1503/cmaj.202642-f
Schreiber M, Ahmad T, Scott M, Imrie K, Razack S. Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine. . CMAJ. 2021 Jun 14;193(24):E937-E941. doi: 10.1503/cmaj.202642-f. French. PMID: 34860696; PMCID: PMC8248460.
Copy Download .nbib Format: NLM
Showing 289 to 290 of 290 entries